These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 979648)

  • 41. Acute in vivo stimulatory effects of human pituitary lipid-mobilizing factor on plasma levels of glucagon and insulin in rabbits.
    Knudtzon J; Winsnes A; Oyasaeter S; Foss I; Trygstad O
    Horm Metab Res; 1984 Dec; 16 Suppl 1():1-6. PubMed ID: 6398246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of substance P and neurotensin on somatostatin levels in rat portal plasma.
    Saito H; Saito S
    Endocrinology; 1980 Nov; 107(5):1600-5. PubMed ID: 6159202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
    Holst JJ; Burcharth F; Kühl C
    Diabete Metab; 1980 Jun; 6(2):117-27. PubMed ID: 6997101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the metabolic responses to portal and peripheral infusions of insulin in diabetic dogs.
    Stevenson RW; Parsons JA; Alberti KG
    Metabolism; 1981 Aug; 30(8):745-52. PubMed ID: 7022105
    [No Abstract]   [Full Text] [Related]  

  • 45. Glucagon-like peptide-1 (7-37) augments insulin release in elderly patients with diabetes.
    Meneilly GS; McIntosh CH; Pederson RA; Habener JF; Gingerich R; Egan JM; Elahi D
    Diabetes Care; 2001 May; 24(5):964-5. PubMed ID: 11347771
    [No Abstract]   [Full Text] [Related]  

  • 46. Enhanced uptake of insulin and glucagon by liver in rats adapted to a high protein diet.
    Demigné C; Fafournoux P; Rémésy C
    J Nutr; 1985 Aug; 115(8):1065-72. PubMed ID: 3894601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma glucagon, insulin and glucose responses to intravenous arginine infusion in the rat.
    Kuku SF; Jaspan JB; Emmanouel DS; Katz AI; Rubenstein AH
    Horm Metab Res; 1978 Mar; 10(2):99-100. PubMed ID: 649048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog.
    Igawa K; Mugavero M; Shiota M; Neal DW; Cherrington AD
    Diabetes; 2002 Oct; 51(10):3033-42. PubMed ID: 12351444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurohumoral control of ileal electrolyte transport. II. Neurotensin and substance P.
    Kachur JF; Miller RJ; Field M; Rivier J
    J Pharmacol Exp Ther; 1982 Mar; 220(3):456-63. PubMed ID: 6174727
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
    Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V
    Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of insulin and glucagon secretion in goats.
    de Jong A
    Ann Rech Vet; 1979; 10(2-3):240-3. PubMed ID: 394655
    [No Abstract]   [Full Text] [Related]  

  • 52. Haemorrhage-induced increases in glucose, glucagon and insulin levels are blocked by naloxone in rats.
    Johansen O; Sundsfjord J; Vaaler S; Jorde R; Tønnesen T; Burhol P; Reikerås O
    Eur J Surg; 1994 Aug; 160(8):403-7. PubMed ID: 7811825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucose-dependent action of glucagon-like peptide-1 (7-37) in vivo during short- or long-term administration.
    Hargrove DM; Nardone NA; Persson LM; Parker JC; Stevenson RW
    Metabolism; 1995 Sep; 44(9):1231-7. PubMed ID: 7666800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of hepatic portal glucose concentration on food intake and metabolism.
    Tordoff MG; Tluczek JP; Friedman MI
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1474-80. PubMed ID: 2690650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fasting and postabsorptive hepatic glucose and insulin metabolism in hyperthyroidism.
    Raboudi N; Arem R; Jones RH; Chap Z; Pena J; Chou J; Field JB
    Am J Physiol; 1989 Jan; 256(1 Pt 1):E159-66. PubMed ID: 2643338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans.
    Larsson H; Holst JJ; Ahrén B
    Acta Physiol Scand; 1997 Aug; 160(4):413-22. PubMed ID: 9338524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of hepatic portal infusion of hypertonic saline on glucagon response to exercise.
    Latour MG; Bergeron R; Lavoie JM
    Physiol Behav; 1999 Sep; 67(3):377-83. PubMed ID: 10497956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of hypoxia on glucose, insulin, glucagon, and modulation by corticotropin-releasing factor receptor type 1 in the rat.
    Chen XQ; Dong J; Niu CY; Fan JM; Du JZ
    Endocrinology; 2007 Jul; 148(7):3271-8. PubMed ID: 17379644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of intraduodenal nutrient infusion on insulin response to subsequent intravenous glucose in rats.
    Ikeda T; Yoshida T; Honda M; Ito Y; Mokuda O; Tominaga M; Mashiba H
    Metabolism; 1987 Oct; 36(10):979-82. PubMed ID: 3309548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the modifying effects of somatostatin and propranolol on morphine-induced changes in glucose, glucagon and insulin levels in fed rats.
    Johansen O; Jorde R; Tønnesen T; Burhol PG; Tveita T; Reikerås O
    Life Sci; 1993; 52(2):141-6. PubMed ID: 8102765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.